US Bancorp’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

US Bancorp’s Portfolio ELAT Stock Details ELAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-212	Closed	-$4.14K	–	4259
2022 Q4	$4.14K	Hold	212	–	–	﹤0.01%	3581
2022 Q3	$4K	Hold	212	–	–	﹤0.01%	3698
2022 Q2	$7K	Hold	212	–	–	﹤0.01%	3496
2022 Q1	$9K	Hold	212	–	–	﹤0.01%	3435
2021 Q4	$9K	Hold	212	–	–	﹤0.01%	3484
2021 Q3	$11K	Buy	+212	New	+$11K	﹤0.01%	3414

US Bancorp's ELAT Position: Q1 2023 in Review

US Bancorp sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 212 shares — an estimated $4.14K sold.

US Bancorp first reported a position in ELAT in Q3 2021 and held it in 6 quarters. The position peaked at $11K in Q3 2021. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

US Bancorp reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
US Bancorp sold 212 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $4.14K.
US Bancorp first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q3 2021 and held it in 6 quarters.
US Bancorp's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $11K in Q3 2021.
0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on US Bancorp's 13F filing for Q1 2023, filed 9 May 2023.